Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases.
Leung D, Chan EY, Mu X, Rosa Duque JS, Cheng SMS, Ho FT, Tong PC, Lai WM, Lee MHL, Chim S, Tam IYS, Tsang LCH, Kwan KKH, Chung Y, Wong HHW, Lee AMT, Li WY, Sze STK, Lam JHY, Lee DHL, Chan SM, Tu W, Peiris M, Ma AL, Lau YL. Leung D, et al. Among authors: tsang lch. Kidney Int Rep. 2023 Aug 28;8(11):2356-2367. doi: 10.1016/j.ekir.2023.08.014. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025215 Free PMC article.
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination.
Cheng SMS, Mok CKP, Leung YWY, Ng SS, Chan KCK, Ko FW, Chen C, Yiu K, Lam BHS, Lau EHY, Chan KKP, Luk LLH, Li JKC, Tsang LCH, Poon LLM, Hui DSC, Peiris M. Cheng SMS, et al. Among authors: tsang lch. Nat Med. 2022 Mar;28(3):486-489. doi: 10.1038/s41591-022-01704-7. Epub 2022 Jan 20. Nat Med. 2022. PMID: 35051989 Free PMC article.
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine.
Leung NHL, Cheng SMS, Martín-Sánchez M, Au NYM, Ng YY, Luk LLH, Chan KCK, Li JKC, Leung YWY, Tsang LCH, Chaothai S, Kwan KKH, Ip DKM, Poon LLM, Leung GM, Peiris JSM, Cowling BJ. Leung NHL, et al. Among authors: tsang lch. Clin Infect Dis. 2023 Feb 8;76(3):e299-e307. doi: 10.1093/cid/ciac458. Clin Infect Dis. 2023. PMID: 35675370 Free PMC article. Clinical Trial.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Rosa Duque JS, Wang X, Leung D, Cheng SMS, Cohen CA, Mu X, Hachim A, Zhang Y, Chan SM, Chaothai S, Kwan KKH, Chan KCK, Li JKC, Luk LLH, Tsang LCH, Wong WHS, Cheang CH, Hung TK, Lam JHY, Chua GT, Tso WWY, Ip P, Mori M, Kavian N, Leung WH, Valkenburg S, Peiris M, Tu W, Lau YL. Rosa Duque JS, et al. Among authors: tsang lch. Nat Commun. 2022 Jun 28;13(1):3700. doi: 10.1038/s41467-022-31485-z. Nat Commun. 2022. PMID: 35764637 Free PMC article.
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Rosa Duque JS, Wang X, Leung D, Cheng SMS, Cohen CA, Mu X, Hachim A, Zhang Y, Chan SM, Chaothai S, Kwan KKH, Chan KCK, Li JKC, Luk LLH, Tsang LCH, Wong WHS, Cheang CH, Hung TK, Lam JHY, Chua GT, Tso WWY, Ip P, Mori M, Kavian N, Leung WH, Valkenburg S, Peiris M, Tu W, Lau YL. Rosa Duque JS, et al. Among authors: tsang lch. Nat Commun. 2022 Aug 15;13(1):4798. doi: 10.1038/s41467-022-32337-6. Nat Commun. 2022. PMID: 35970832 Free PMC article. No abstract available.
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection.
Cheng SS, Mok CK, Li JK, Ng SS, Lam BH, Jeevan T, Kandeil A, Pekosz A, Chan KC, Tsang LC, Ko FW, Chen C, Yiu K, Luk LL, Chan KK, Webby RJ, Poon LL, Hui DS, Peiris M. Cheng SS, et al. J Clin Virol. 2022 Nov;156:105273. doi: 10.1016/j.jcv.2022.105273. Epub 2022 Aug 31. J Clin Virol. 2022. PMID: 36081282 Free PMC article.
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.
Leung D, Mu X, Duque JSR, Cheng SMS, Wang M, Zhang W, Zhang Y, Tam IYS, Lee TSS, Lam JHY, Chan SM, Cheang CH, Chung Y, Wong HHW, Lee AMT, Li WY, Chaothai S, Tsang LCH, Chua GT, Cheong KN, Au EYL, Kwok JSY, Chan KW, Chong PCY, Lee PPW, Ho MHK, Lee TL, Tu W, Peiris M, Lau YL. Leung D, et al. Among authors: tsang lch. Front Immunol. 2022 Sep 20;13:982155. doi: 10.3389/fimmu.2022.982155. eCollection 2022. Front Immunol. 2022. PMID: 36203563 Free PMC article. Clinical Trial.
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.
Mu X, Cohen CA, Leung D, Rosa Duque JS, Cheng SMS, Chung Y, Wong HHW, Lee AMT, Li WY, Tam IYS, Lam JHY, Lee DHL, Chan SM, Tsang LCH, Chan KCK, Li JKC, Luk LLH, Chaothai S, Kwan KKH, Chu NC, Mori M, Jeevan T, Kandeil A, Webby RJ, Tu W, Valkenburg SA, Peiris M, Lau YL. Mu X, et al. Among authors: tsang lch. Signal Transduct Target Ther. 2022 Dec 14;7(1):397. doi: 10.1038/s41392-022-01282-7. Signal Transduct Target Ther. 2022. PMID: 36517469 Free PMC article.
19 results